UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

European Society of Hypertension Practice Guidelines for home blood pressure monitoring

Journal of human hypertension, 2010-12, Vol.24 (12), p.779-785

2010

Volltextzugriff (PDF)

Management of hypertension in the very old: aggressive reduction of blood pressure is harmful in most patients

Journal of human hypertension, 2020-09, Vol.34 (8), p.557-559

2020

Volltextzugriff (PDF)

Blood pressure and renal function: therapeutic implications

Journal of hypertension, 1996-11, Vol.14 (11), p.1259-1263

1996

Volltextzugriff (PDF)

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)

The Lancet (British edition), 2000-07, Vol.356 (9227), p.366-372

2000

Volltextzugriff (PDF)

Interpreting treatment-induced blood pressure reductions measured by ambulatory blood pressure monitoring

Journal of human hypertension, 2013-12, Vol.27 (12), p.715-720

2013

Volltextzugriff (PDF)

Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK study

Journal of human hypertension, 2007-06, Vol.21 (6), p.479-485

2007

Volltextzugriff (PDF)

Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study

Diabetologia, 2010-01, Vol.53 (1), p.49-57

2010

Volltextzugriff (PDF)

Modification over time of pulse wave velocity parallel to changes in aortic BP, as well as in 24-h ambulatory brachial BP

Journal of human hypertension, 2016-03, Vol.30 (3), p.186-190

2016

Volltextzugriff (PDF)

Renal function and target organ damage in hypertension

European heart journal, 2011-07, Vol.32 (13), p.1599-1604

2011

Volltextzugriff (PDF)

Heart rate and heart rate variability in resistant versus controlled hypertension and in true versus white-coat resistance

Journal of human hypertension, 2014-07, Vol.28 (7), p.416-420

2014

Volltextzugriff (PDF)

Prognostic Value of Ambulatory Blood Pressure Monitoring in Refractory Hypertension: A Prospective Study

Hypertension (Dallas, Tex. 1979), 1998-02, Vol.31 (2), p.712-718

1998

Volltextzugriff (PDF)

Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial

The Lancet (British edition), 2009-07, Vol.374 (9683), p.26-26

2009

Volltextzugriff (PDF)

Counteracting aldosterone in cardiorenal disease in type 2 diabetes through finerenone administration

Hipertension y riesgo vascular, 2023-04, Vol.40 (2), p.55-57

2023

Volltextzugriff (PDF)

Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors

Biomedicine & pharmacotherapy, 2023-12, Vol.168, p.115661-115661, Article 115661

2023

Volltextzugriff (PDF)

Angiotensin-II receptor blockers: benefits beyond blood pressure reduction?

Journal of human hypertension, 2005-05, Vol.19 (5), p.331-339

2005

Volltextzugriff (PDF)

New antihypertensive drugs under development

Current medicinal chemistry, 2015-01, Vol.22 (3), p.305-342

2015

Volltextzugriff (PDF)

Telmisartan 80 mg/hydrochlorothiazide 25 mg single-pill combination in the treatment of hypertension

Expert opinion on pharmacotherapy, 2012-11, Vol.13 (16), p.2417-2425

2012

Volltextzugriff (PDF)

Oral health, hypertension and cardiovascular diseases

Hipertensión y riesgo vascular, 2023-10, Vol.40 (4), p.167-170

2023

Volltextzugriff (PDF)

Microvascular injury and the kidney in hypertension

Hipertension y riesgo vascular, 2018-01, Vol.35 (1), p.24-29

2018

Volltextzugriff (PDF)

Office and ambulatory pulse pressure-association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study)

Journal of human hypertension, 2011-11, Vol.25 (11), p.679-685

2011

Volltextzugriff (PDF)

Control of hypertension in coronary heart disease

International journal of cardiology, 2009-05, Vol.134 (2), p.245-247

2009

Volltextzugriff (PDF)

Estimating the impact of obesity and metabolic phenotype on sickness absence. Results from the ICARIA study

Nutrition, metabolism, and cardiovascular diseases, 2019-04, Vol.29 (4), p.383-389

2019

Volltextzugriff (PDF)

Uric acid as a cardiovascular risk factor in arterial hypertension

Journal of hypertension, 1999-07, Vol.17 (7), p.869-872

1999

Volltextzugriff (PDF)

The need for combination antihypertensive therapy to reach target blood pressures: what has been learned from clinical practice and morbidity-mortality trials?

International journal of clinical practice (Esher), 2007-09, Vol.61 (9), p.1592-1602

2007

Volltextzugriff (PDF)

A COMPARISON BETWEEN USUAL OFFICE AND FOUR OTHER METHODS TO EVALUATE BLOOD PRESSURE (BP-TRUE, HBPM, ABPM AND CBP) DURING 3 YEARS FOLLOW-UP

Journal of hypertension, 2018-06, Vol.36 Suppl 1 - ESH 2018 Abstract Book (Supplement 1), p.e136-e136

2018

Volltextzugriff (PDF)

1 – 25 von 784

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(739)
Mit Volltextzugriff
(634)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(431)
Life Sciences & Biomedicine
(388)
Science & Technology
(388)
Male
(236)
Cardiovascular System & Cardiology
(226)
Biological And Medical Sciences
(199)
Medical Sciences
(197)
Female
(192)
Middle Aged
(177)
Hypertension - Drug Therapy
(174)
Peripheral Vascular Disease
(167)
Adult
(127)
Antihypertensive Agents - Therapeutic Use
(121)
Hypertension
(121)
Aged
(118)
Hypertension - Physiopathology
(105)
Pharmacology. Drug Treatments
(103)
Blood Pressure - Drug Effects
(98)
Risk Factors
(92)
Hypertension - Complications
(88)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

European Society of Hypertension Practice Guidelines for home blood pressure monitoring

Management of hypertension in the very old: aggressive reduction of blood pressure is harmful in most patients

Blood pressure and renal function: therapeutic implications

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)

Interpreting treatment-induced blood pressure reductions measured by ambulatory blood pressure monitoring

Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK study

Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study

Modification over time of pulse wave velocity parallel to changes in aortic BP, as well as in 24-h ambulatory brachial BP

Renal function and target organ damage in hypertension

Heart rate and heart rate variability in resistant versus controlled hypertension and in true versus white-coat resistance

Prognostic Value of Ambulatory Blood Pressure Monitoring in Refractory Hypertension: A Prospective Study

Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial

Counteracting aldosterone in cardiorenal disease in type 2 diabetes through finerenone administration

Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors

Angiotensin-II receptor blockers: benefits beyond blood pressure reduction?

New antihypertensive drugs under development

Telmisartan 80 mg/hydrochlorothiazide 25 mg single-pill combination in the treatment of hypertension

Oral health, hypertension and cardiovascular diseases

Microvascular injury and the kidney in hypertension

Office and ambulatory pulse pressure-association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study)

Control of hypertension in coronary heart disease

Estimating the impact of obesity and metabolic phenotype on sickness absence. Results from the ICARIA study

Uric acid as a cardiovascular risk factor in arterial hypertension

The need for combination antihypertensive therapy to reach target blood pressures: what has been learned from clinical practice and morbidity-mortality trials?

A COMPARISON BETWEEN USUAL OFFICE AND FOUR OTHER METHODS TO EVALUATE BLOOD PRESSURE (BP-TRUE, HBPM, ABPM AND CBP) DURING 3 YEARS FOLLOW-UP

Suchergebnisse filtern